ENTITY
Ligand Pharmaceuticals

Ligand Pharmaceuticals (LGND US)

18
Analysis
Health Care • United States
Ligand Pharmaceuticals Incorporated develops drugs which regulate hormone activated intracellular receptors. These receptors play a role in regulating the genetic processes affecting diseases such as gynecological disorders, certain cancers, as well as cardiovascular, inflammatory, and skin diseases.
more
Exchange Announcement • 18 May 2026 21:01
Exchange Announcement • 08 May 2026 08:00
Exchange Announcement • 07 May 2026 19:03
Exchange Announcement • 01 May 2026 04:41
Exchange Announcement • 27 Apr 2026 21:29
x